Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119477) titled 'Efficacy, Influencing Factors, and Changes in Cardiovascular Disease Risk Associated with the Use of Albuvirtide (ABT) to Promote Immune Reconstitution in Treated HIV-1-Infected Patients with Immunological Non-responder' on Feb. 27.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Guangzhou Eighth Peoples Hospital Guangzhou Medical University
Condition:
HIV/AIDS
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-16
Target Sample Size: Research group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...